Pay in 4 interest-free payments of $6.30 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
B.LiberlesS
That can feel empowering
The LIRA-RENAL Trial (Once-Daily Liraglutide) The Efficacy and Safety of Liraglutide Versus Placebo as Add-on to Glucose-Lowering Therapy in Patients With Type 2 Diabetes and Moderate Renal Impairment (LIRA-RENAL) trial investigated the efficacy and safety of liraglutide as an add-on to existing glucose-lowering medications in people with inadequately controlled T2DM and moderate renal impairment (stage 3 CKD, eGFR 3059 ml/min/1.73 m 2 ) [48]
Your body knows how to heal
Contact us today to learn about your legal options
Glucagon-like peptide-1 (GLP-1) receptor agonists represent a class of medications originally developed for type 2 diabetes management and now widely prescribed for chronic weight management
US$ 24.35
US$ 28.49
US$ 24.58
US$ 25.78
US$ 22.95
US$ 22.24
US$ 23.95
US$ 29.42
US$ 20.55
